Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Recommendation of “Buy” from Brokerages
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average […]
Shares of Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average […]